Literature DB >> 16802201

Focal liver lesions: sinusoidal phase of CEUS.

M D'Onofrio1, E Martone, N Faccioli, G Zamboni, R Malagò, R Pozzi Mucelli.   

Abstract

Ultrasound examination is the first imaging modality for hepatic study in neoplastic and chronic liver diseases. Focal liver lesions frequently cause diagnostic problems in terms of characterization, especially when small and hypoechoic to the rest of the parenchyma. Contrast--enhanced ultrasonography (CEUS) has shown its value in the characterization of focal liver lesions. This study assessed the value of the sinusoidal phase of CEUS with a second-generation contrast agent in the characterization of focal liver lesions to distinguish benign from malignant. Two hundred hepatic lesions with suspicious features at baseline ultrasound were prospectively studied with CEUS. Sensitivity, specificity, positive and negative predictive values, and diagnostic accuracy of the sinusoidal phase in the characterization of benign versus malignant liver lesions were evaluated. Hypoechogenicity of the focal liver lesion, during the sinusoidal phase of CEUS, allowed the diagnosis of malignancy with a sensitivity of 85%, specificity of 88%, positive predictive value of 92%, negative predictive value of 77%, and diagnostic accuracy of 86%. The diagnostic confidence in the diagnosis of malignancy significantly increased, with receiver operating characteristic curve areas from 0.536 for baseline ultrasound to 0.902 for the sinusoidal phase of CEUS.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16802201     DOI: 10.1007/s00261-005-0066-5

Source DB:  PubMed          Journal:  Abdom Imaging        ISSN: 0942-8925


  16 in total

1.  Malignant focal liver lesions at contrast-enhanced ultrasonography and magnetic resonance with hepatospecific contrast agent.

Authors:  M D'Onofrio; S Crosara; R De Robertis; S Canestrini; V Cantisani; G Morana; R Pozzi Mucelli
Journal:  Ultrasound       Date:  2013-12-13

2.  Characterisation of focal liver lesions undetermined at grey-scale US: contrast-enhanced US versus 64-row MDCT and MRI with liver-specific contrast agent.

Authors:  T V Bartolotta; A Taibbi; M Midiri; L La Grutta; M De Maria; R Lagalla
Journal:  Radiol Med       Date:  2010-01-15       Impact factor: 3.469

3.  Asian Pacific Association for the Study of the Liver consensus recommendations on hepatocellular carcinoma.

Authors:  Masao Omata; Laurentius A Lesmana; Ryosuke Tateishi; Pei-Jer Chen; Shi-Ming Lin; Haruhiko Yoshida; Masatoshi Kudo; Jeong Min Lee; Byung Ihn Choi; Ronnie T P Poon; Shuichiro Shiina; Ann Lii Cheng; Ji-Dong Jia; Shuntaro Obi; Kwang Hyub Han; Wasim Jafri; Pierce Chow; Seng Gee Lim; Yogesh K Chawla; Unggul Budihusodo; Rino A Gani; C Rinaldi Lesmana; Terawan Agus Putranto; Yun Fan Liaw; Shiv Kumar Sarin
Journal:  Hepatol Int       Date:  2010-03-18       Impact factor: 6.047

4.  Algorithm-based approach to focal liver lesions in contrast-enhanced ultrasound.

Authors:  Kheng Song Leow; Christine Ying Kwok; Hsien Min Low; Rahul Lohan; Tze Chwan Lim; Su Chong Albert Low; Cher Heng Tan
Journal:  Australas J Ultrasound Med       Date:  2022-07-04

5.  Contrast-enhanced ultrasonography in the characterization of benign focal liver lesions: activity-based cost analysis.

Authors:  N Faccioli; M D'Onofrio; A Comai; C Cugini
Journal:  Radiol Med       Date:  2007-09-20       Impact factor: 3.469

6.  Intrahepatic peripheral cholangiocarcinoma (IPCC): comparison between perfusion ultrasound and CT imaging.

Authors:  M D'Onofrio; F Vecchiato; V Cantisani; E Barbi; M Passamonti; P Ricci; R Malagò; N Faccioli; G Zamboni; R Pozzi Mucelli
Journal:  Radiol Med       Date:  2008-02-25       Impact factor: 3.469

7.  Can contrast-enhanced ultrasonography characterize focal liver lesions and differentiate between benign and malignant, thus providing a one-stop imaging service for patients?().

Authors:  D D Cokkinos; M J Blomley; C J Harvey; A Lim; C Cunningham; D O Cosgrove
Journal:  J Ultrasound       Date:  2007-10-23

8.  Focal liver lesions in cirrhosis: value of contrast-enhanced ultrasonography compared with Doppler ultrasound and alpha-fetoprotein levels.

Authors:  M D'Onofrio; N Faccioli; G Zamboni; R Malagò; S Caffarri; G Fattovich; R Pozzi Mucelli
Journal:  Radiol Med       Date:  2008-09-08       Impact factor: 3.469

9.  Detection of focal liver lesions: from the subjectivity of conventional ultrasound to the objectivity of volume ultrasound.

Authors:  F Vecchiato; M D'Onofrio; R Malagò; E Martone; A Gallotti; N Faccioli; V Cantisani; C Marigliano; A Ruzzenente; R Pozzi Mucelli
Journal:  Radiol Med       Date:  2009-06-23       Impact factor: 3.469

Review 10.  Small liver lesions in oncologic patients: characterization with CT, MRI and contrast-enhanced US.

Authors:  Giovanni Morana; Christian Cugini; Raffaella Pozzi Mucelli
Journal:  Cancer Imaging       Date:  2008-10-04       Impact factor: 3.909

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.